MedPath

Bronchial Colonization With Fungi and Late Respiratory Acquired Pneumonia

Not Applicable
Completed
Conditions
Ventilator Acquired Pneumonia
Interventions
Procedure: biological sampling
Procedure: sampling blood
Procedure: endotracheal aspiration
Registration Number
NCT01770015
Lead Sponsor
University Hospital, Grenoble
Brief Summary

Ventilator acquired pneumonia (VAP) are severe nosocomial infections. On the other side, bronchial fungi colonization is commonly observed in ICU; therefore, the investigators propose to study the role of bronchial fungi colonization on the occurrence of VAP taking into account the immune status of the patient and the antibiotic and antifungal treatments he has received.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
213
Inclusion Criteria
  • patient ventilated for at least 5 days
Exclusion Criteria
  • invasive infection Candida sp defined by : candidemia, isolation of Candida from a normally sterile site, candida pneumoniae.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ventilated patientbiological samplingall patients underwent the same diagnostic test . cutaneous, rectal, nose and mouth swabs to identify potential fungi colonization. HLA DR antigen, cytokines (IL 6 and 10), B-glucan. fungi and bacteria endotracheal aspiration
ventilated patientsampling bloodall patients underwent the same diagnostic test . cutaneous, rectal, nose and mouth swabs to identify potential fungi colonization. HLA DR antigen, cytokines (IL 6 and 10), B-glucan. fungi and bacteria endotracheal aspiration
ventilated patientendotracheal aspirationall patients underwent the same diagnostic test . cutaneous, rectal, nose and mouth swabs to identify potential fungi colonization. HLA DR antigen, cytokines (IL 6 and 10), B-glucan. fungi and bacteria endotracheal aspiration
Primary Outcome Measures
NameTimeMethod
Onset of a late ventilator acquired pneumonia (VAP)Participants will be followed for the duration of mechanical ventilation, an expected time frame that can go from 5 days to up to 8 weeks
Secondary Outcome Measures
NameTimeMethod
Onset of a pseudomonas aeruginosa associated VAPParticipants will be followed for the duration of mechanical ventilation, an expected time frame that can go from 5 days to up to 8 weeks
Onset of late ventilator associated pneumonia associated to staphylococcus aureusParticipants will be followed for the duration of mechanical ventilation, an expected time frame that can go from 5 days to up to 8 weeks

Trial Locations

Locations (2)

Hospital University Clermont Ferrand Gabriel Montpied

🇫🇷

Clermont-Ferrand, France

University Hospital of Grenoble

🇫🇷

Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath